The reported in vivo effects of PPARδ activation include improvement of dylipidemia and hyperglycemia, prevention of diet-induced obesity, enhancement of insulin sensitivity and modulation of muscle fiber type switching as demonstrated by systemic ligand administration or by generation of transgenic mice that over-express an active PPARδ [4]–[7]. The gene discussed is INS; the disease is Obesity.